movfor molnupiravir 200 mg
1,500 - 1,600 Per Bottle
10 BOTTLE (MOQ)
MOVFOR is an oral experimental antiviral drug which contains Molnupiravir. It exerts its antiviral action through introduction of copying errors during viral RNA replication. As per the studies performed in covid-19 patients, Molnupiravir has shown to shorten the time to recovery in some people.
MOLNUNAT Capsules
Get Price Quote
Specifications :- Brand Name : MOLNUNAT Content : Molnupiravir Manufactured by : NATCO Strength : 200 mg Packing : pack of 40 Capsules From : Capsules Note :- MOLNUNAT is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug....
Best Deals from Molnupiravir
Molnupiravir Capsules 200 Mg (Covid Pill)
150 - 380 Per 100 per
1 Bottle (MOQ)
Product Description Molnupiravir is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.
Molnupiravir Pharmaceutical Chemical
25,000 - 30,000 Per kg
1 Kilogram (MOQ)
Molnupiravir Capsules
2,000 - 2,200 Per Bottle
10 Bottle (MOQ)
Product Description Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication. The drug was developed at Emory University by the university's drug innovation company, Drug Innovation Ventures at Emory (DRIVE). It was then acquired by Miami-based company Ridgeback Biotherapeutics, who later partnered with Merck & Co. to develop the drug further. Safety controversyIn April 2020, a whistleblower complaint by former Head of US Biomedical Advanced Research and Development Authority (BARDA) Rick Bright revealed concerns over providing funding for the further development of molnupiravir due to similar drugs having mutagenic (DNA damaging) properties.[3] A previous company, Pharmasset, that had investigated the drug's active ingredient had abandoned it. These claims were denied by George Painter, CEO of DRIVE, noting that toxicity studies on molnupiravir had been carried out and data provided to regulators in the US and UK, who permitted safety studies in humans to move forward in the spring of 2020. Also at this time, DRIVE and Ridgeback Biotherapeutics stated they planned future safety studies in
Molilow 200 Capsules
Get Price Quote
50 Pack (MOQ)
0.0
Website
Molnupiravir 200mg Capsule
310 Per 160 Capsule
160 Capsule (MOQ)
Molnupiravir Capsules
Get Price Quote
100 Box (MOQ)
Molnupiravir 200mg Capsule
Get Price Quote
200 Box (MOQ)
MOVFOR Capsules
1,499 Per Bottle
100 Box (MOQ)
Modawake 200mg Tablets
300 Per Strip
50 Box (MOQ)
Molnupiravir
426 - 430 Per Kilogram
25 Kilogram (MOQ)
Molnupiravir Capsules
Get Price Quote
50 Pack (MOQ)
Molnuvid Capsules
1,900 Per Bottle
100 Bottle (MOQ)
Molnupiravir 200mg Capsules
Get Price Quote
10 Box (MOQ)
Molnupiravir Capsules
Get Price Quote
Molnatris tm capsules
2,000 - 3,000 Per capsules
10 Pack (MOQ)
MOLNUPIRAVIR 200MG CAP.
2,000 - 2,500 Per BOTTLE
TREATMENT OF COVID
0.0
View Profile
Molnupiravir Capsules
3,500 Per Bottle
to treat mild to moderate covid 19
0.0
View Profile
Molnupiravir
Get Price Quote
0.0
View Profile
Post Free Ad
